Previous Close | 46.83 |
1-Year Change | 58.58% |
6-Months Change | 23.27% |
3-Months Change | 17.19% |
Moving Avg (50d) | 48.769 |
Moving Avg (200d) | 43.754 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 3.2B |
Beta (3-Years) | 1.74 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -121.37% |
EPS (ttm) | -7.22 |
PE Ratio (ttm) | -6.49 |
Dividend Yield | % |
Asset Description: | Biohaven Ltd. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
45.893 | 44.489 | 43.552 | 42.147 | 39.806 | 37.464 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |